The Great Reshoring Debate Post-COVID
Access insights from a roundtable discussion held at CPHI Frankfurt 2022, where top-level leaders from Leon Nanodrugs, Rx 360, Medicines for Europe, PepGen, Syngene International, and US Pharmacopeia gathered to discuss overcoming the supply chain challenges that pharma continues to grapple with post COVID-19.
Capture insider perspectives on:
- Active pharmaceutical ingredient (API) production and sourcing challenges
- Reshoring vs. diversification of supply chain sources
- Facilitating reshoring via regulatory changes
- Supporting manufacturers investing in technology and process optimization
23 January 2023